Abstract
The tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) is a valuable biomarker for human exposure to the carcinogenic nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in tobacco and tobacco smoke. In this work, an efficient and sensitive method for the analysis of NNAL in human hair was developed and validated. The hair sample was extracted by NaOH solution digestion, purified by C18 solid-phase extraction (SPE) and molecularly imprinted solid-phase extraction, further enriched by reverse-phase ultrasound-assisted dispersive liquid–liquid microextraction (USA-DLLME) into 1.0 % aqueous formic acid, and finally analyzed by liquid chromatography–electrospray ionization tandem mass spectrometry. Good linearity was obtained in the range of 0.24–10.0 pg/mg hair with a correlation coefficient of 0.9982, when 150 mg hair was analyzed. The limit of detection and lower limit of quantification were 0.08 and 0.24 pg/mg hair, respectively. Accuracies determined from hair samples spiked with three different levels of NNAL ranged between 87.3 and 107.7 %. Intra- and inter-day relative standard deviations varied from 4.1 to 8.5 % and from 6.9 to 11.3 %, respectively. Under the optimized conditions, an enrichment factor of 20 was obtained. Finally, the developed method was applied for the analysis of NNAL in smokers' hair. The proposed sample preparation procedure combining selectivity of two-step SPE and enrichment of DLLME significantly improves the purification and enrichment of the analyte and should be useful to analyze NNAL in hair samples for cancer risk evaluation and cancer prevention in relation to exposure to the tobacco-specific carcinogen NNK.
Similar content being viewed by others
References
Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P (2002) Oncogene 21:7435–7451
Hecht SS (2003) Nat Rev Cancer 3:733–744
Shah KA, Halquist MS, Karnes HT (2009) J Chromatogr B 877:1575–1582
Carmella SG, Han SM, Villalta PW, Hecht SS (2005) Cancer Epidemiol Biomarkers Prev 14:2669–2672
Pan JW, Song Q, Shi HH, King M, Junga H, Zhou SL, Weng ND (2004) Rapid Commun Mass Spectrom 18:2549–2557
Stepanov I, Hecht SS, Lindgren B, Jacob P, Wilson M, Benowitz NL (2007) Cancer Epidemiol Biomarkers Prev 16:1382–1386
Jacob P, Havel C, Lee D-H, Yu L, Eisner MD, Benowitz NL (2008) Anal Chem 80:8115–8121
Kempson IM, Lombi E (2011) Chem Soc Rev 40:3915–3940
Srogi K (2006) Anal Lett 39:231–258
Pragst F, Balikova MA (2006) Clin Chim Acta 370:17–49
Zimmerman CL, Wu Z, Upadhyaya P, Hecht SS (2004) Carcinogenesis 25:1237–1242
Carmella SG, Han SM, Fristad A, Yang YY, Hecht SS (2003) Cancer Epidemiol Biomarkers Prev 12:1257–1261
Bhat SH, Gelhaus SL, Mesaros C, Vachani A, Blair IA (2011) Rapid Commun Mass Spectrom 25:115–121
Yang Y, Yu C, Zhou M, Pang N, Li N, Nie H, Liao J, Bai Y, Liu H (2011) J Chromatogr A 1218:6505–6510
Lee HL, Wang C, Lin S, Hsieh DPH (2007) Talanta 73:76–80
Byrd GD, Ogden MW (2003) J Mass Spectrom 38:98–107
Fan JP, Zhang L, Zhang XH, Huang JZ, Tong S, Kong T, Tian ZY, Zhu JH (2012) Anal Bioanal Chem 402:1337–1346
Ambrosini S, Shinde S, De Lorenzi E, Sellergren B (2012) Analyst 137:249–254
Yan H, Qiao J, Wang H, Yang G, Row KH (2011) Analyst 136:2629–2634
Yang J, Hu Y, Cai JB, Zhu XL, Su QD (2006) Anal Bioanal Chem 384:761–768
Xia Y, McGuffey JE, Bhattacharyya S, Sellergren B, Yimaz E, Wang LQ, Bernert JT (2005) Anal Chem 77:7639–7645
Cordero C, Zebelo SA, Gnavi G, Griglione A, Bicchi C, Maffei ME, Rubiolo P (2012) Anal Bioanal Chem 402:1941–1952
Da Fonseca P, Bonato PS (2010) Anal Bioanal Chem 396:817–824
Gao W, Chen G, Chen Y, Li N, Chen T, Hu Z (2011) J Chromatogr A 1218:5712–5717
Costas-Mora I, Romero V, Pena-Pereira F, Lavilla I, Bendicho C (2011) Anal Chem 83:2388–2393
Saleh A, Larsson E, Yamini Y, Jonsson JA (2011) J Chromatogr A 1218:1331–1339
Simoes RA, Moraes de Oliveira AR, Bonato PS (2011) Anal Bioanal Chem 399:2435–2443
Hashemi P, Raeisi F, Ghiasvand AR, Rahimi A (2010) Talanta 80:1926–1931
Rezaee M, Assadi Y, Hosseinia M-RM, Aghaee E, Ahmadi F, Berijani S (2006) J Chromatogr A 1116:1–9
Li P, Zhu X, Hong S, Tian Z, Yang J (2012) Anal Methods 4:995–1000
Liao X, Liang B, Li Z, Li Y (2011) Analyst 136:4580–4586
Yang CY, Ding WH (2012) Anal Bioanal Chem 402:1723–1730
Xia Y, Zhi X, Wang X, Chen M, Cheng J (2012) Anal Bioanal Chem 402:1241–1247
Montes R, Rodriguez I, Ramil M, Rubi E, Cela R (2009) J Chromatogr A 1216:5459–5466
Liu B, Yan H, Qiao F, Geng Y (2011) J Chromatogr B 879:90–94
Liu X, Li J, Zha Z, Zhang W, Lin K, Huang C, Wang X (2009) J Chromatogr A 1216:2220–2226
Samadi S, Sereshti H, Assadi Y (2012) J Chromatogr A 1219:61–65
Stepanov I, Feuer R, Jensen J, Hatsukami D, Hecht SS (2006) Cancer Epidemiol Biomarkers Prev 15:2378–2383
Carmella SG, Le KA, Upadhyaya P, Hecht SS (2002) Chem Res Toxicol 15:545–550
Wang WX, Yang TJ, Li ZG, Jong TT, Lee MR (2011) Anal Chim Acta 690:221–227
Melwanki MB, Fuh M-R (2008) J Chromatogr A 1198:1–6
Shah KA, Peoples MC, Halquist MS, Rutan SC, Karnes HT (2011) J Pharm Biomed Anal 54:368–378
Acknowledgments
The authors gratefully acknowledge the financial support from the Key Laboratory of Cigarette Smoke Research of China National Tobacco Corporation (SZBCW201100780) and the fundamental research funds for the central universities (WK2061020001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yao, L., Yang, J., Guan, Yf. et al. Development, validation, and application of a liquid chromatography–tandem mass spectrometry method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human hair. Anal Bioanal Chem 404, 2259–2266 (2012). https://doi.org/10.1007/s00216-012-6356-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-012-6356-1